The Impact of Needleless Connector Device Design on Central Venous Catheter Occlusion in Children: A Prospective,Controlled Trial

Abstract

Background: Intraluminal occlusion is common in children with central venous catheters (CVCs). Although multiple factors predispose CVCs to occlusion, reflux of blood is frequently implicated. We hypothesized that use of either a single-valve or positive-pressure-valve needleless connector device would reduce CVC occlusion rates in comparison to a standard device. We further hypothesized that saline would be as effective as heparinized saline flush in preventing occlusion and infection. Methods: CVC lumens were prospectively capped with 1 of 3 needleless connector devices in a 4-group design. Group 1 lumens were capped with a standard device, group 2 with a single-valve device, group 3 with a positive-pressure-valve device flushed with heparinized saline, and group 4 with a positive-pressure-valve device flushed with saline. Data were obtained regarding occlusion and infection rates and user satisfaction. Results: Three hundred sixty children with 599 CVC lumens completed the study. Complete occlusion occurred in 19/150 (12.7%) lumens in group 1 in comparison to 2/150 (1.3%) in group 2, 5/149 (3.4%) in group 3, and 6/150 (4%) in group 4 (p < .05). There was a trend toward a 2-fold greater infection rate in group 4. User satisfaction was higher in groups 2, 3, and 4 than group 1 (p < .05). Conclusions: CVCs capped with a single-valve or positive-pressure-valve needleless connector device have lower complete catheter occlusion rates than those capped with a standard device. Heparinized saline flush affords no advantages over saline in reducing occlusion rate; however, there was a trend toward lower infection rate with the use of heparinized saline.

Use of either single-valve or positive-pressure-valve needleless connector devices to cap central venous catheters significantly reduces the rate of complete catheter occlusion in comparison to standard needleless connector devices in children.

Get full access to this article

View all access options for this article.

References

Stephens LC, Haire WD, Kotulak GD. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr. 1995 ;19:75– 79.

Hoch JR. Management of the complications of long term venous access. Semin Vasc Surg. 1997 ;10:135– 143.

Jacobs BR. Central venous catheter occlusion and thrombosis. Crit Care Clin. 2003 ;19:489– 514.

Rumsey KA, Richardson DK. Management of infection and occlusion associated with vascular access devices. Semin Oncol Nurs. 1995;11:174– 183.

Krzywda EA. Predisposing factors, prevention and management of central venous catheter occlusions. J Intraven Nurs. 1999 ;22(6 suppl):S11– S17.

Jacobs BR, Schilling S, Doellman D, Hutchinson N, Rickey M, Nelson S. Central venous catheter occlusion: a prospective, controlled trial examining the impact of a positive-pressure valve device. JPEN J Parenter Enteral Nutr. 2004 ;28:113– 118.

Rummel MA, Donnelly PJ, Fortenbaugh C. Clinical evaluation of a positive pressure device to prevent central venous catheter occlusion: results of a pilot study. Clin J Oncol Nurs. 2001 ;5:261– 265.

O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections: the Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Pediatrics. 2002 ;110:e51 .

Garner IS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control. 1988; 16:128– 140.

10.

Deitcher SR, Fesen MR, Kiproff PM, et al. Safety and efficiency of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombotic to open occluded lines trial. J Clin Oncol. 2002;20:317– 324.

11.

Racadio JM, Doellman DA, Johnson ND, Bean JA, Jacobs BA. Pediatric peripherally inserted central catheters: complication rates related to catheter tip location. Pediatrics. 2001 ;107:E28 .

12.

Fratino G, Molinari A, Mazzola C, et al. Prospective study of indwelling central venous catheter-related complications in children with Broviac or clampless valved catheters. J Pediatr Hematol Oncol. 2002;24:657– 661.

13.

Andris DA, Krzywda EA, Schulte W, Ausman R, Quebbeman EJ. Pinch off syndrome: a rare etiology for central venous catheter occlusions. JPEN J Parenter Enteral Nutr. 1994 ;18:531– 533.

14.

Cassidy FP, Zajko AB, Bron KM, Reilly JJ, Peitzman AB, Steed DL. Noninfectious complications of long term central venous catheters: radiology evaluation and management. Am J Radiol. 1987 ;149:671– 675.

15.

Knue M, Doellman D, Rabin K, Jacobs BR. The efficacy and safety of blood sampling through peripherally inserted central catheter devices in children. J Infus Nurs. 2005 ;28:30– 35.

16.

Shah PS, Ng E, Sinha AK. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database Syst Rev. 2004;4CD002774 .

17.

Rabe C, Gramann T, Sons X, et al. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med. 2002;28:1172– 1176.

18.

Meyer BA, Little CJ, Thorp JA, Cohen GR, Yeast JD. Heparin versus normal saline as a peripheral line flush in maintenance of intermittent intravenous lines in obstetric patients. Obstet Gyncol. 1995;85:433– 436.

19.

Terry J, Baranowski L, Lonsway RA, Hedrick C, eds. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: Saunders; 1995.

20.

Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev. 2001 ; CD002772.

21.

Hadaway LC. Major thrombolytic and non-thrombolytic complications: loss of patency. J Intraven Nurs. 1998 ;21(5 suppl):S143– S160.

22.

Hoshal VL, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg. 1991;102:353– 357.

23.

Cheeseman D. Intravenous care: the benefits of closed-system connectors. B J Nurs. 2001 ;10:287– 295.

24.

Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the Posiflow needleless connector. J Hosp Infect. 2003;54:288– 293.

25.

Elliott TS, Curran A. Effects of heparin and chlorbutol on bacterial colonization of intravascular cannulae in an in vitro model. J Hosp Infect. 1989 ;14:193– 200.

26.

Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled studies. Chest. 1998 ;113:165– 171.

27.

Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr. 2001 ;139:593– 596.